@article{4bd618aebf6f4fe2963a9e34d3efa8fc,
title = "Emerging therapeutic targets for the treatment of nicotine addiction",
abstract = "In summary, there has been a dramatic increase in the number of potential therapeutic agents currently in development for smoking cessation for which nAChRs are not the primary site of action. This represents our growing understanding of the mechanisms of nicotine addiction. Animal models have played a critical role in driving much of the progress in this area and promise to reveal many new therapeutic targets for smoking cessation therapeutics over the coming years.",
author = "Kenny, {Paul J.}",
note = "Funding Information: This paper was supported by the National Institute on Drug Abuse (DA020686), and The James and Esther King Biomedical Research Program, Florida Department of Health (07KN-06). This is manuscript number 20049 from The Scripps Research Institute. The author has no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.",
year = "2009",
doi = "10.1586/ecp.09.6",
language = "English",
volume = "2",
pages = "221--225",
journal = "Expert Review of Clinical Pharmacology",
issn = "1751-2433",
publisher = "Taylor and Francis Ltd.",
number = "3",
}